143 related articles for article (PubMed ID: 38336188)
1. Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
Wang Y; Fu Q; Park SY; Lee YS; Park SY; Lee DY; Yoon S
Biotechnol Adv; 2024; 71():108322. PubMed ID: 38336188
[TBL] [Abstract][Full Text] [Related]
2. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
Lin YC; Lu M; Cai W; Hu WS
Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
[TBL] [Abstract][Full Text] [Related]
3. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
5. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity.
Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS
Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988
[TBL] [Abstract][Full Text] [Related]
6. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
7. Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells.
Chung CH; Murphy CM; Wingate VP; Pavlicek JW; Nakashima R; Wei W; McCarty D; Rabinowitz J; Barton E
Mol Ther Methods Clin Dev; 2023 Mar; 28():272-283. PubMed ID: 36819978
[TBL] [Abstract][Full Text] [Related]
8. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.
Destro F; Joseph J; Srinivasan P; Kanter JM; Neufeld C; Wolfrum JM; Barone PW; Springs SL; Sinskey AJ; Cecchini S; Kotin RM; Braatz RD
Mol Ther Methods Clin Dev; 2023 Sep; 30():122-146. PubMed ID: 37746245
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms.
Catalán-Tatjer D; Tzimou K; Nielsen LK; Lavado-García J
Biotechnol Adv; 2024; 73():108370. PubMed ID: 38692443
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells.
Nguyen TNT; Sha S; Hong MS; Maloney AJ; Barone PW; Neufeld C; Wolfrum J; Springs SL; Sinskey AJ; Braatz RD
Mol Ther Methods Clin Dev; 2021 Jun; 21():642-655. PubMed ID: 34095346
[TBL] [Abstract][Full Text] [Related]
12. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
13. Construction of an rAAV Producer Cell Line through Synthetic Biology.
Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
[TBL] [Abstract][Full Text] [Related]
14. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
[TBL] [Abstract][Full Text] [Related]
15. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
16. Development of a Novel Recombinant Adeno-Associated Virus Production System Using Human Bocavirus 1 Helper Genes.
Wang Z; Cheng F; Engelhardt JF; Yan Z; Qiu J
Mol Ther Methods Clin Dev; 2018 Dec; 11():40-51. PubMed ID: 30397626
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells.
Cao TM; Chen D; Barnard GC; Shen A
Biotechnol Bioeng; 2024 Jan; 121(1):395-402. PubMed ID: 37902721
[TBL] [Abstract][Full Text] [Related]
18. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
19. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
20. A novel and highly efficient production system for recombinant adeno-associated virus vector.
Wu Z; Wu X; Cao H; Dong X; Wang H; Hou Y
Sci China C Life Sci; 2002 Feb; 45(1):96-104. PubMed ID: 18763068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]